+ All Categories
Home > Documents > Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations,...

Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations,...

Date post: 20-Dec-2015
Category:
View: 220 times
Download: 0 times
Share this document with a friend
35
Pain Pain Management: Management: a Regulatory a Regulatory Perspective Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor State Medical Board of Ohio
Transcript
Page 1: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Pain Pain Management:Management:

a Regulatory a Regulatory PerspectivePerspectiveWilliam J. Schmidt, J.D.

Senior Counsel, Investigations, Compliance & Enforcement

Randy BeckInvestigative Supervisor

State Medical Board of Ohio

Page 2: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

OVERVIEWOVERVIEW• Organization of Medical Board

• Key provisions of pain management statutes & rules

Page 3: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

State Medical Board of OhioState Medical Board of Ohio

The Medical Board is

a state regulatory

agency

founded in 1896

Page 4: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Board OrganizationBoard Organization

To protect and enhance the health

and safety of the public through

effective medical regulation

Mission

Page 5: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Structure

12 members appointed by Governor to

staggered five-year terms; may be

reappointed

7 MD’s, 1 DO, 1 DPM, and 3 consumer

representatives

Monthly meetings in Columbus

Board OrganizationBoard Organization

Page 6: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Operations

• 87 full time employees

• $ 8 million plus annual operating

budget funded solely by licensing &

renewal fees

• No money from general revenue fund

Board OrganizationBoard Organization

Page 7: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Approximately 60,000 professionals*, including

Medical Doctors MD 35,872

Doctors of Osteopathic Medicine DO 4,788

Doctors of Podiatric Medicine DPM 956

Licensed Massage Therapists LMT 10,699

Physician Assistants PA 1,886

Anesthesiologist Assistants AA 129

Acupuncturists A or RAC 147

Cosmetic Therapists CT 209

Doctors in training 5,214

MEDICAL BOARD LICENSEESMEDICAL BOARD LICENSEES

* and c*and coming soon… Radiologist Assistants Data as of 12-31-08

Page 8: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Regulatory AuthorityRegulatory Authority

STATUTES - Chapters 4730, 4731, 4760,

4762 & 4774, Ohio Revised Code

RULES - Chapters 4730, 4731 & 4774 Ohio Administrative Code

Medical Board interprets & enforces

statutes and rules

Page 9: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

The Medical The Medical Board’sBoard’s

Pain Management Pain Management GuidelinesGuidelines

Page 10: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

The Medical Board has never taken an action against a physician for the appropriate use of

medication

Page 11: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

The Medical Board has never taken an action against a physician for the treatment of cancer

pain

Page 12: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Ohio Intractable Ohio Intractable Pain Statute – October 1997Pain Statute – October 1997

• Section 4731.052, Ohio Revised Code

• Required Medical Board to write rules defining standards & procedures for diagnosing & treating intractable pain

Page 13: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Ohio Intractable Pain StatuteOhio Intractable Pain Statute

Physician who manages

intractable pain with dangerous

drugs in accordance with law not

subject to Medical Board

disciplinary action

Page 14: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

The Medical The Medical Board’sBoard’s

Pain Management Pain Management RulesRules

Chapter 4731-21, O.A.C.

Page 15: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Medical Board RulesMedical Board Rules

Intractable pain is not

– Pain associated with a terminal condition, or

– Pain associated with a disease that may be expected to result in a terminal condition

Page 16: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Rules do not apply to . . .Rules do not apply to . . .

Treatment using only non-CNS

drugs or antidepressants

Page 17: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Rules apply only to . . .Rules apply only to . . .

Treatment on a protracted basis

Use of amounts & combinations of drugs that may not be appropriate in other conditions

For example:

• Using doses far exceeding PDR’s usual recommended dosage

• Adding opioids for breakthrough pain

Page 18: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Requirements for Requirements for Treating Intractable PainTreating Intractable Pain

Page 19: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Initial Evaluation Initial Evaluation 4731-21-02, O.A.C4731-21-02, O.A.C.

• Patient history, including alcohol & substance abuse

• Assessment of pain impact on function

• Review of previous studies & therapies• Assessment of coexisting illnesses• Physical exam

Page 20: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Medical DiagnosisMedical Diagnosis

Document presence of intractable pain

Identify signs, symptoms & causes

• Nature of underlying disease• Pain mechanism

Page 21: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Individualized Treatment PlanIndividualized Treatment Plan

Specify medical justification for drugs and role of drug therapy

Document drugs that did not succeed, adjust drug therapy

Document response

Modify treatment plan as necessary

Page 22: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Evaluation by SpecialistEvaluation by Specialist

• Must specialize in treatment of anatomic area, system or organ perceived as pain source

• Evaluator must review prior treatment records & prepare written report

• Referring physician must keep copy of specialist’s report

• May assume patient’s care, but usually acts as a consultant

Page 23: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Evaluation not required …Evaluation not required …

if patient had prior satisfactory evaluation within reasonable time

if treating physician has records of prior evaluation

Page 24: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Informed ConsentInformed Consent

• Obtain from patient or person having authority to consent

• Inform of benefits & risks of treatment

• Inform of treatment alternatives

• Document in patient record

Page 25: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

• need for using more than one controlled substance in pain treatment

• patient’s name & address, dates, amounts, dosage forms & refills of all prescription drugs

Consider use of duplicate prescription forms

Be Sure to DocumentBe Sure to Document

Page 26: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Other ConsiderationsOther Considerations

• Consider Pain Contract with patient– Consequences of non-compliance– Expectation of refills & follow-up visits

• Consider urine sample for drug screening to confirm patient’s use

• Ohio Automated Prescription Reporting System (OARRS) report

Page 27: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

OARRSOARRS

• Ohio Automated Prescription Reporting System, a prescription monitoring program overseen by Ohio Board of Pharmacy

• OARRS contains dispensing information for all controlled substances, carisoprodol products and tramadol products within the past 2 years

• Physicians may register for OARRS access to review patient prescription history reports

Page 28: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

OARRS RegistrationOARRS Registration

www.ohiopmp.gov for registration information to obtain a user name and password

Patient prescribing report requested on-line; data from January 1, 2006 provided; turn around time is about 15 minutes for report

Approximate 25 day lag time in data entry, as pharmacies send dispensing reports to OARRS twice a month

Page 29: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Patient Follow-UpPatient Follow-Up

• Periodically assess treatment efficacy

• Assure drug therapy still indicated

• Evaluate progress toward treatment objectives

• Note functional ability & quality of life

• Consider drug screens

• Consider OARRS report review

Page 30: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Obtain Objective MeasuresObtain Objective Measures

• Ability to engage in work

• Pain intensity & interference with life

• Family & social activities

• Physical activity

Page 31: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Suspected drug abuse?Suspected drug abuse?

Physician may obtain a drug screen if there are indications of drug abuse

Consult with substance abuse specialist

Page 32: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

If drug abuse suspected If drug abuse suspected

• Continue therapy consistent with specialist’s recommendations

• Refer patient to substance abuse specialist if recommended

• Continue to monitor for signs of abuse• Keep copy of any report from consultant• If termination of patient is considered, refer to

Rule 4731-27, OAC

Page 33: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

Tolerance and physical dependence do not

always equal addiction or require cessation

of opioid therapy

Page 34: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

med.ohio.govmed.ohio.gov

Medical Board website has links to:

Pain Rules (Chapter 4731-21, OAC)

Policy – Office-based Treatment of Opioid Addiction

Page 35: Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.

State Medical Board of State Medical Board of OhioOhio

30 E. Broad St. 3rd FloorColumbus, OH 43215-6127

Phone: 614-466-3934

FAX: 614-728-5946

MED.OHIO.GOV


Recommended